Categories: News

Eargo to Report Third Quarter 2022 Financial Results on November 3, 2022

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

SAN JOSE, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) — Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve hearing health, today announced it will release financial results for the third quarter 2022 after market close on November 3, 2022. On the same day, Eargo will host a conference call and webcast at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss its financial results and recent highlights.

Interested parties may access the live call via telephone by dialing (888)-599-8686 for domestic callers or (323)-794-2588 for international callers, using conference ID: 8304019. The live webinar of the call may also be accessed by visiting the Events and Presentations section of Eargo’s website at ir.eargo.com. A replay of the webinar will be available shortly after the conclusion of the call and will be archived on Eargo’s website for one year.

About Eargo
Eargo is a medical device company on a mission to improve hearing health. Our innovative products and go-to-market approach address the major challenges of traditional hearing aid adoption, including social stigma, accessibility and cost. We believe our Eargo hearing aids are the first virtually invisible, rechargeable, completely-in-canal, FDA-regulated, Class I or Class II exempt devices indicated to compensate for mild to moderate hearing loss. Our differentiated, consumer-first approach empowers consumers to take control of their hearing. Consumers can purchase online or over the phone and get personalized and convenient consultation and support from hearing professionals via phone, text, email or video chat. The Eargo device is offered to consumers at approximately half the cost of competing hearing aids purchased through traditional channels in the United States.

Eargo’s sixth generation device, Eargo 6, is an FDA Class II exempt hearing device featuring Sound Adjust technology that automatically optimizes the soundscape as the user moves between environments. Eargo 6 is available for purchase here.

Related Links
http://eargo.com

Investor Contact
Nick Laudico
Senior Vice President of Corporate Strategy and Investor Relations
ir@eargo.com

Staff

Recent Posts

Aesthetic Partners Welcomes Healthcare Leader Mark Censoprano to Its Board Leadership Team

MIAMI, July 28, 2025 /PRNewswire/ -- Aesthetic Partners, a leading medical aesthetics and plastic surgery…

5 hours ago

IMV Announces Initial Winners of 2025 ServiceTrak™ Clinical Laboratory Awards, Honored at ADLM Annual Conference

ARLINGTON, Va., July 28, 2025 /PRNewswire/ -- IMV, part of the Science and Medicine Group…

5 hours ago

Trella Health Releases 2025 Post-Acute Care Industry Trend Report Highlighting Continued Medicare Advantage Growth and Shifts in Care Utilization

New annual report reveals national and state-level trends across home health, hospice, and skilled nursing.…

5 hours ago

$10 Million Philanthropic Donation Launches Research Effort into Root Causes of Stuttering

COSTA MESA, Calif., July 28, 2025 /PRNewswire/ -- The newly founded Stuttering Treatment and Research Society…

5 hours ago

CORRECTION FROM THE SOURCE: FloraWorks Highlights New Study Showing CBN Reverses Cognitive Decline in Aging Mice

Peer-reviewed research published in Redox Biology supports the therapeutic potential of Cannabinol (CBN) in brain…

10 hours ago